Strong link between bone biomarkers and prostate cancer survival
Prostate cancer is the second leading cause of death in American men. Understanding the factors that…
Browsing: androgen deprivation therapy
ESMO 2022: Highlights on ADT duration with post-operative radiotherapy in prostate cancer: RADICALS-HD
Researchers contribute to discovery of mechanism leading to drug resistance in prostate cancer
Prostate cancer is the most common cancer among men in the United States. Many patients…
New meta-analysis: Planning for patients with high-risk prostate cancer
Results of a large study led by UCLA Jonsson Comprehensive Cancer Center, USA, researchers could…
International meta-analysis quantifies impact of three prostate cancer therapy intensification strategies
An individual patient data (IPD) meta-analysis of randomised, controlled clinical trials provides strong evidence for…
Exercise now proven to have mental health benefits for prostate cancer
New Edith Cowan University (ECU) research has found that exercise not only has physical benefits…
Inflammation from ADT may cause fatigue in prostate cancer patients
Prostate cancer is one of the most common cancers among men. For many patients, hormone…
New Research Finds Low Bone Health Testing Rates after Prostate Cancer Treatment
New research in the October 2020 issue of the Journal of the National Comprehensive Cancer…
Exercise works for those beginning prostate cancer treatment
An international group led by Professor John Saxton from Northumbria University and the University of…
Football training may preserve bone health in prostate cancer patients
Androgen deprivation therapy for the treatment of prostate cancer can lead to loss of muscle…